Japanese life insurer Dai-ichi Life has made a takeover approach for Australian annuities and retirement income provider Challenger. The non-binding, indicative proposal, made through its Australian unit TAL Dai-ichi Life Australia and disclosed on Monday, 19 October 2026, values Challenger at about A$7.94 billion (around US$5.5 billion).
The offer
- Price: A$11.80 per share in cash.
- Premium: about 19.8% above Challenger's closing price on Friday, 16 October.
- Existing stake: Dai-ichi already owns about 20.36% of Challenger, up from roughly 15% in mid-2025. The bid is for the remaining shares.
Conditions
The proposal depends on several steps:
- Satisfactory due diligence
- Approval from Australia's Foreign Investment Review Board
- Approval from the prudential regulator, APRA
- A unanimous recommendation from Challenger's board
Challenger, which manages around A$31.9 billion, said its board is evaluating the terms with its advisers.
Why Dai-ichi wants Challenger
Japan's big insurers have been expanding overseas to find growth beyond their slow-growing, ageing home market. Australia is attractive because of its large and compulsory superannuation (retirement savings) system, which creates steady demand for products that turn savings into a regular income in retirement, Challenger's core business.
What happens next
A non-binding proposal is only a first step. If due diligence goes well and the board backs the offer, the companies could move to a binding agreement, followed by regulatory approvals and a shareholder vote. Analysts will watch whether other bidders emerge and whether Challenger's board pushes for a higher price.
A busy time for deals
The approach adds to a strong period for global mergers and acquisitions, as large companies use strong balance sheets to buy growth across borders, particularly in financial services and insurance.
This article is based on reports available as of 19 October 2026. Market figures move quickly and may have changed since publication.
